![Conor Kilroy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Conor Kilroy
General Counsel at
AURA BIOSCIENCES, INC.
Net worth: 2 M $ as of 2026-05-30
Profile
Conor Kilroy is currently Secretary & Chief Legal Officer at Aura Biosciences, Inc., starting in 2025.
Former positions include Secretary & General Counsel at Neurogastrx, Inc. from 2021 to 2023; Secretary, Senior Vice President & General Counsel at Ironwood Pharmaceuticals, Inc. from 2020 to 2021; Counsel at Boston Scientific Corp.
from 2012 to 2013; and Associate at Goodwin Procter LLP from 2007 to 2011.
Education includes undergraduate studies at Brandeis University and graduate studies at Boston College Law School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AURA BIOSCIENCES INC 0.37% | 2026-06-30 | 232,693 ( 0.37% ) | 2 M $ | 2026-05-30 |
Conor Kilroy active positions
| Companies | Position | Start |
|---|---|---|
| AURA BIOSCIENCES, INC. | General Counsel | 2024-03-31 |
Former positions of Conor Kilroy
| Companies | Position | End |
|---|---|---|
Neurogastrx, Inc.
 Neurogastrx, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops transformative therapies for gastrointestinal disorders | General Counsel | 2023-04-30 |
| IRONWOOD PHARMACEUTICALS, INC. | General Counsel | 2021-01-31 |
| BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | 2012-12-31 |
Goodwin Procter LLP
 Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Corporate Officer/Principal | 2010-12-31 |
Training of Conor Kilroy
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
62
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Boston Scientific Corp.
 Boston Scientific Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiology, endoscopy, peripheral intervention, urology & neuromodulation equipment | Health Technology |
Ironwood Pharmaceuticals, Inc.
 Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Aura Biosciences, Inc.
 Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Goodwin Procter LLP
Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Finance |
Brandeis University
 Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston College Law School
 Boston College Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops transformative therapies for gastrointestinal disorders | Health Technology |
- Stock Market
- Insiders
- Conor Kilroy
